DexCom
DXCM
Collegium Pharmaceutical
COLL
Lantheus
LNTH
4
Precision Drilling
PDS
5
Workday
WDAY
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|
Total revenue | 2.28%101.88M | -10.82%90.63M | -13.72%90.01M | 0.32%390.12M | 84.54M | 99.61M | 101.63M | 104.33M | 388.87M |
Operating revenue | 2.35%98.88M | -13.19%86.32M | -14.61%87.19M | -0.18%379.22M | --81.07M | --96.61M | --99.43M | --102.11M | --379.91M |
Cost of revenue | 18.98%19.84M | 22.27%18.96M | 7.41%17.93M | 11.14%66.42M | 17.54M | 16.68M | 15.51M | 16.7M | 59.76M |
Gross profit | -1.08%82.04M | -16.78%71.67M | -17.75%72.08M | -1.64%323.7M | 67.01M | 82.94M | 86.12M | 87.64M | 329.11M |
Operating expense | 39.67%92.75M | 4.10%80.53M | 8.17%81.89M | 15.65%301.05M | 81.57M | 66.41M | 77.37M | 75.7M | 260.3M |
Selling and administrative expenses | 41.22%74.47M | 1.93%63.3M | 7.54%65.17M | 14.98%241.78M | --65.34M | --52.73M | --62.1M | --60.6M | --210.28M |
-Selling and marketing expense | 109.81%47.15M | -19.21%32.36M | -13.37%33.64M | 10.95%147.93M | --46.57M | --22.47M | --40.05M | --38.84M | --133.33M |
-General and administrative expense | -9.72%27.32M | 40.34%30.94M | 44.83%31.53M | 21.96%93.85M | --18.77M | --30.26M | --22.05M | --21.77M | --76.96M |
Research and development costs | 30.42%16.44M | 10.36%15M | 9.92%14.89M | 11.51%52.16M | --12.41M | --12.61M | --13.59M | --13.55M | --46.77M |
Depreciation amortization depletion | 72.09%1.85M | 33.39%2.23M | 17.80%1.83M | 93.86%6.79M | --3.49M | --1.07M | --1.67M | --1.55M | --3.5M |
-Depreciation and amortization | 72.09%1.85M | 33.39%2.23M | 17.80%1.83M | 93.86%6.79M | --3.49M | --1.07M | --1.67M | --1.55M | --3.5M |
Provision for doubtful accounts | ---- | ---- | ---- | 228.45%324.91K | ---- | ---- | ---- | ---- | ---252.95K |
Operating profit | -164.83%-10.71M | -201.25%-8.87M | -182.22%-9.81M | -67.08%22.65M | -14.56M | 16.53M | 8.76M | 11.93M | 68.81M |
Net non-operating interest income expense | 0 | 1.41M | |||||||
Non-operating interest income | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --1.41M |
Other net income (expense) | 163.68%1.47M | -126.30%-1.42M | 99.26%-26.49K | 45.42%-2.48M | -1.98M | -2.32M | 5.39M | -3.57M | -4.54M |
Gain on sale of security | ---- | ---- | ---- | -141.67%-2.3M | ---- | ---- | ---- | ---- | --5.51M |
Special income (charges) | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---11.5M |
-Gain on sale of business | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---11.5M |
Other non- operating income (expenses) | 163.68%1.47M | -126.30%-1.42M | 99.26%-26.49K | -112.42%-180.8K | --315.3K | ---2.32M | --5.39M | ---3.57M | --1.46M |
Income before tax | -165.02%-9.24M | -172.70%-10.28M | -217.60%-9.84M | -69.28%20.18M | -16.54M | 14.21M | 14.14M | 8.36M | 65.69M |
Income tax | -95.31%331.22K | -75.97%1.4M | -55.89%2.72M | -49.89%16.14M | -2.88M | 7.06M | 5.81M | 6.16M | 32.21M |
Net income | -229.86%-9.57M | -230.08%-11.68M | -505.63%-12.55M | -88.37%5.82M | -13.62M | 7.37M | 8.98M | 3.09M | 50.08M |
Net income continuous Operations | -233.74%-9.57M | -240.20%-11.68M | -668.30%-12.55M | -87.94%4.04M | ---13.66M | --7.16M | --8.33M | --2.21M | --33.47M |
Net income discontinuous operations | --0 | --0 | --0 | -89.25%1.78M | --37.19K | --213.62K | --647.91K | --885.75K | --16.6M |
Minority interest income | -1,686.63%-120.92K | -33.25%-104.6K | -132.56%-121.82K | -247.3K | -124.03K | 7.62K | -78.5K | -52.38K | 0 |
Net income attributable to the parent company | -228.36%-9.45M | -227.80%-11.58M | -495.01%-12.43M | -87.88%6.07M | -13.5M | 7.36M | 9.06M | 3.15M | 50.08M |
Preferred stock dividends | |||||||||
Other preferred stock dividends | -204.64%-645.89M | 12.17%11.1M | 1,089.60%1.09B | 561.51%340.08M | 652.12M | -212.02M | 9.89M | -109.91M | 51.41M |
Net income attributable to common stockholders | 190.11%636.44M | -2,615.37%-22.67M | -1,073.05%-1.1B | -24,973.56%-334.01M | -665.62M | 219.38M | -834.95K | 113.06M | -1.33M |
Basic earnings per share | 190.11%1.3855 | -2,614.80%-0.0494 | -1,073.05%-2.3949 | -24,973.00%-0.7271 | -1.449 | 0.4776 | -0.0018 | 0.2461 | -0.0029 |
Diluted earnings per share | 190.11%1.3855 | -2,614.80%-0.0494 | -1,073.05%-2.3949 | -24,973.00%-0.7271 | -1.449 | 0.4776 | -0.0018 | 0.2461 | -0.0029 |
Dividend per share | |||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD |